Journey Medical Corporation (DERM)

Company Overview

Journey Medical is focused on strategically identifying, acquiring, and successfully commercializing innovative and differentiated dermatology products. The Journey team is comprised of industry experts with decades of experience commercializing some of the most successful prescription dermatology brands. Our market knowledge and experience allow us to identify undervalued assets and future opportunities, then commercialize these opportunities through a best-in-dermatology marketing and sales organization.

Download Presentation View Management Team

Latest News

Nov 4, 2024 • 7:00am EST

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Read Press Release

Oct 25, 2024 • 8:30am EDT

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Oct 3, 2024 • 8:30am EDT

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 9, 2024 • 8:30am EDT

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

View All SEC Filings

Q2 2024

Quarter Ended Jun 30, 2024

Earnings Release

Audio

Earnings Webcast

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Contacts

Corporate

Journey Medical Corporation
9237 East Via De Ventura
Suite 105
Scottsdale, AZ 85258
T: 480-434-6670
contact@jmcderm.com

Investor Relations

Jaclyn Jaffe
T: 781-652-4500
ir@jmcderm.com

Transfer Agent

VStock Transfer
Allison Niccolls
allison@vstocktransfer.com